|
MBX MBX Biosciences Inc 1776111 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-37,095,000.00 |
| Balance Sheet |
|
Current Assets
|
$427,862,000.00 |
|
Assets
|
$435,909,000.00 |
|
Current Liabilities
|
$23,660,000.00 |
|
Liabilities
|
$26,370,000.00 |
|
Equity
|
$409,539,000.00 |
|
Shares Out
|
47949804.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-42,830,000.00 |
|
Investing Cash Flow
|
$-67,887,000.00 |
| Market Analysis |
Market Cap
|
$3,181,469,495.40 |
|
Price
|
$66.35 |
|
BVPS
|
8.54 |
|
PB
|
7.77 |
|
EPS
|
-0.78 |
|
FCF
|
$-44,168,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:21 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.49 |
|
|
2026-05-07 |
-0.51 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.58 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.63 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MBX documents filed with the SEC.
MBX Filings
Clear
